{"result": {"id": "349778d6-095f-4786-b755-8b605bb4772e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>TC<|>ORGANIZATION<|>TC refers to Total Cholesterol, a measure used in assessing lipid levels in the blood)\n##\n(\"entity\"<|>LDL-C<|>ORGANIZATION<|>LDL-C refers to Low-Density Lipoprotein Cholesterol, often termed 'bad cholesterol' due to its association with cardiovascular disease)\n##\n(\"entity\"<|>HDL-C<|>ORGANIZATION<|>HDL-C refers to High-Density Lipoprotein Cholesterol, often termed 'good cholesterol' due to its protective role against cardiovascular disease)\n##\n(\"entity\"<|>BMI<|>ORGANIZATION<|>BMI stands for Body Mass Index, a measure used to assess body fat based on height and weight)\n##\n(\"entity\"<|>LVMI<|>ORGANIZATION<|>LVMI stands for Left Ventricular Mass Index, a measure used to assess left ventricular hypertrophy)\n##\n(\"entity\"<|>IMT<|>ORGANIZATION<|>IMT stands for Intima-Media Thickness, a measure used to assess arterial wall thickness)\n##\n(\"entity\"<|>eGFR<|>ORGANIZATION<|>eGFR stands for estimated Glomerular Filtration Rate, a measure used to assess kidney function)\n##\n(\"entity\"<|>CCB<|>ORGANIZATION<|>CCB stands for Calcium Channel Blocker, a class of drugs used to treat hypertension and other cardiovascular conditions)\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>ACEI stands for Angiotensin-Converting Enzyme Inhibitor, a class of drugs used to treat hypertension and heart failure)\n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>ARB stands for Angiotensin II Receptor Blocker, a class of drugs used to treat hypertension and other cardiovascular conditions)\n##\n(\"relationship\"<|>TC<|>LDL-C<|>Both TC and LDL-C are measures of cholesterol levels in the blood<|>7)\n##\n(\"relationship\"<|>TC<|>HDL-C<|>Both TC and HDL-C are measures of cholesterol levels in the blood<|>7)\n##\n(\"relationship\"<|>LDL-C<|>HDL-C<|>LDL-C and HDL-C are both types of cholesterol with opposing roles in cardiovascular health<|>8)\n##\n(\"relationship\"<|>BMI<|>LVMI<|>BMI can influence LVMI as obesity is a risk factor for left ventricular hypertrophy<|>6)\n##\n(\"relationship\"<|>IMT<|>eGFR<|>Both IMT and eGFR are measures used to assess cardiovascular and kidney health respectively<|>5)\n##\n(\"relationship\"<|>CCB<|>ACEI<|>Both CCB and ACEI are classes of drugs used to treat hypertension<|>7)\n##\n(\"relationship\"<|>CCB<|>ARB<|>Both CCB and ARB are classes of drugs used to treat hypertension<|>7)\n##\n(\"relationship\"<|>ACEI<|>ARB<|>Both ACEI and ARB are classes of drugs that act on the renin-angiotensin system to treat hypertension<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166340, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 702, "prompt_tokens": 2562, "total_tokens": 3264, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 770}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: >55岁；女性>65岁\n· 吸烟或被动吸烟\n· 糖耐量受损\n餐后2h血糖7.8~11.0 mmol/L和/或 空腹血糖异常(6.1~6.9mmol/L)\n· 血脂异常\nTC≥5.2 mmol/L(200 mg/dl)或LDL-C≥ 3.4 mmol/L(130 mg/dl),HDL-C<1.0\nmmol/L(40 mg/dl)\n· 早发心血管病家族史  一级亲属发病年龄<50岁\n· 腹型肥胖\n腰围：男性≥90cm,女性≥85cm 或BMI≥28 kg/m2\t· 左心室肥厚\n心电图：Sokolow-Lyon电压>3.8mV或 Cornell乘积>244mV ·ms\n超声心动图LVMI:男≥115g/m2,女≥95g/m2\n●颈动脉超声： IMT≥0.9mm或动脉粥样 斑 块\n●eGFR降低[eGFR30~59ml ·min-1 · (1.73m2)-1]或\n血清肌酐轻度升高：\n男性115~133μmol/L(1.3~1.5mg/d),\n女性107~124 μmol/L(1.2~1.4 mg/dl)\n·微量白蛋白尿30~300 mg/24h;\n\n或尿白蛋白肌酐比≥30mg/g(3.5mg/mmol)\t· 脑血管病\n脑出血，缺血性卒中，短暂性脑缺血发作\n· 心脏疾病\n心肌梗死史，心绞痛，冠状动脉血运重建，慢性心力 衰竭，心房颤动\n· 肾脏疾病  糖尿病肾病\n肾功能受损：eGFR<30ml ·min-1 · (1.73m2)-1\n血肌酐升高：男性≥133μmolL(1.5mg/d);女性≥124 μmol/L(1.4mg/dl)\n蛋白尿(≥300 mg/24h)\n· 外周血管疾病\n· 视网膜病变\n出血或渗出，视乳头水肿\n· 糖尿病\n新诊断：空腹血糖≥7.0mmol/L(126mg/dl);餐后 血糖≥11.1mmol/L(200 mg/dl)\n已治疗但未控制：糖化血红蛋白≥6.5%\n注 ：LVMI左心室重量指数；IMT颈动脉内膜中层厚度；eGFR 估算的肾小球滤过率\n( 1 ) 老 年 高 血 压 ：\n\n\n表5高血压临床常用药物的适应证\n\n适应证\tCCB\tACEI\tARB\t利尿剂\tβ受体\n阻滞剂\n左心室肥厚\t+\t+\t+\t±\t±\n稳定性冠心病\t+\t+8\t+e\t-\t+\n心肌梗死后\t-\t+\t+\t+6\tX\n心力衰竭\t_b\t+\t+\t+\t+\n心房颤动预防\t-\t+\t\t\t\n脑血管病\t+\t+\t+\t十\t土\n颈动脉内中膜增厚\t+\t±\t±\t-\t\n蛋白尿/微量白蛋白尿\t-\t+\t+\t-\t-\n肾功能不全\t±\t+\t十\t+e\t\n老年\t+\t+\t+\t\t±\n糖尿病\t±\t+\t+\t±\t\n血脂异常\t±\t+\t+\t\t\n　　注 ：CCB 钙通道阻滞剂(二氢吡啶类);ACEI 血管紧张素转换 酶抑制剂；ARB 血管紧张素�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_0dab77f542cdaa9856962962e41c49bd1c717864de2771382c2bc9f9b30e6792_v2"}